Oppenheimer Holdings, Inc. reiterated their buy rating on shares of K2M Group Holdings, Inc. (NASDAQ:KTWO) in a research report sent to investors on Friday. Oppenheimer Holdings, Inc. currently has a $24.00 price objective on the medical device company’s stock.
KTWO has been the topic of several other research reports. Zacks Investment Research raised K2M Group Holdings from a hold rating to a buy rating and set a $25.00 price target on the stock in a research report on Wednesday, October 4th. Needham & Company LLC reduced their target price on K2M Group Holdings from $27.00 to $26.00 and set a strong-buy rating for the company in a research note on Thursday, November 2nd. Wells Fargo & Company reduced their target price on K2M Group Holdings from $28.00 to $23.00 and set an outperform rating for the company in a research note on Tuesday, October 10th. Royal Bank Of Canada reiterated a buy rating and set a $26.00 target price on shares of K2M Group Holdings in a research note on Friday, September 22nd. Finally, Cowen and Company reiterated an outperform rating and set a $22.00 target price (down from $28.00) on shares of K2M Group Holdings in a research note on Tuesday, October 10th. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating, ten have given a buy rating and one has given a strong buy rating to the stock. The company currently has a consensus rating of Buy and an average price target of $25.00.
K2M Group Holdings (KTWO) traded up $0.01 during trading hours on Friday, hitting $18.59. The company’s stock had a trading volume of 190,300 shares, compared to its average volume of 417,081. K2M Group Holdings has a 52-week low of $17.23 and a 52-week high of $25.99. The company has a current ratio of 3.06, a quick ratio of 1.67 and a debt-to-equity ratio of 0.29.
K2M Group Holdings (NASDAQ:KTWO) last posted its quarterly earnings results on Wednesday, November 1st. The medical device company reported ($0.20) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.19) by ($0.01). The company had revenue of $62.65 million for the quarter, compared to analyst estimates of $62.69 million. K2M Group Holdings had a negative return on equity of 16.02% and a negative net margin of 16.22%. The firm’s revenue for the quarter was up 5.6% compared to the same quarter last year. During the same period last year, the firm earned ($0.19) EPS. research analysts forecast that K2M Group Holdings will post -0.86 EPS for the current fiscal year.
WARNING: This piece was originally reported by BBNS and is the sole property of of BBNS. If you are accessing this piece on another publication, it was copied illegally and reposted in violation of international copyright & trademark legislation. The legal version of this piece can be viewed at https://baseballnewssource.com/markets/k2m-group-holdings-inc-ktwo-receives-buy-rating-from-oppenheimer-holdings-inc/1775616.html.
In other K2M Group Holdings news, insider John Philip Md Kostuik sold 1,332 shares of K2M Group Holdings stock in a transaction on Wednesday, August 23rd. The stock was sold at an average price of $23.30, for a total value of $31,035.60. Following the completion of the transaction, the insider now directly owns 200,629 shares of the company’s stock, valued at approximately $4,674,655.70. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 5.80% of the stock is owned by insiders.
Several institutional investors have recently bought and sold shares of the company. Oppenheimer Asset Management Inc. acquired a new position in shares of K2M Group Holdings during the 3rd quarter worth $347,000. Envestnet Asset Management Inc. acquired a new position in shares of K2M Group Holdings during the 3rd quarter worth $423,000. Elk Creek Partners LLC acquired a new position in shares of K2M Group Holdings during the 3rd quarter worth $7,836,000. Schwab Charles Investment Management Inc. raised its holdings in shares of K2M Group Holdings by 5.4% during the 3rd quarter. Schwab Charles Investment Management Inc. now owns 183,418 shares of the medical device company’s stock worth $3,891,000 after buying an additional 9,348 shares in the last quarter. Finally, Wells Fargo & Company MN raised its holdings in shares of K2M Group Holdings by 50.1% during the 3rd quarter. Wells Fargo & Company MN now owns 95,070 shares of the medical device company’s stock worth $2,017,000 after buying an additional 31,748 shares in the last quarter. 99.92% of the stock is owned by institutional investors.
K2M Group Holdings Company Profile
K2M Group Holdings, Inc is a medical device company focused on designing, developing and commercializing spine and minimally invasive technologies and techniques. The Company’s solutions are focused on achieving three-dimensional Total Body Balance. Its spine products are used by spine surgeons to treat spinal pathologies, such as deformity (primarily scoliosis), trauma and tumor.
Receive News & Ratings for K2M Group Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for K2M Group Holdings Inc. and related companies with our FREE daily email newsletter.